>
CV Sciences Inc logo

CVSI - CV Sciences Inc Share Price

$0.248 0.0  1.2%

Last Trade - 15/10/21

Sector
Healthcare
Size
Micro Cap
Market Cap £19.7m
Enterprise Value £20.0m
Revenue £15.1m
Position in Universe 6426th / 7247
Bullish
Bearish
Unlock CVSI Revenue
Momentum
Relative Strength (%)
1m -3.21%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -77.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
11.5 11.1 20.7 48.2 53.7 24.4 21.1 28.0 +16.2%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2021, CV SciencesInc revenues decreased 27% to $10M. Net loss decreased 32%to $6.7M. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Lower net loss reflects SpecialtyPharmaceutical Segment loss decrease of 90% to $182K,Consumer Products Segment loss decrease of 21% to $6.4M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CVSI Revenue Unlock CVSI Revenue

Net Income

CVSI Net Income Unlock CVSI Revenue

Normalised EPS

CVSI Normalised EPS Unlock CVSI Revenue

PE Ratio Range

CVSI PE Ratio Range Unlock CVSI Revenue

Dividend Yield Range

CVSI Dividend Yield Range Unlock CVSI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CVSI EPS Forecasts Unlock CVSI Revenue
Profile Summary

CV Sciences, Inc. is a life science company. The Company operates through two business segments: consumer product and specialty pharmaceutical. The consumer product segment is focused on developing, manufacturing, marketing and selling plant-based dietary supplements and hemp-based cannabidiol (CBD) products to a range of market sectors. The specialty pharmaceutical segment is focused on developing and commercializing CBD-based therapeutics utilizing CBD. The Company also develops, manufactures, markets and sells plant-based dietary supplements and CBD products under brands, including PlusCBD, PlusCBD Pet, ProCBD, Happy Lane, ProCBD, CV Acute, CV Defense and PlusCBD Pet in the healthcare market sector, including nutraceutical, beauty care, specialty foods and pet products. The Company’s consumer products are marketed and sold at approximately 7,300 retail locations throughout the United States.

Directors
Last Annual December 31st, 2020
Last Interim June 30th, 2021
Incorporated July 26, 2013
Public Since October 4, 2018
No. of Shareholders: 37
No. of Employees: 91
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 109,018,698
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
CVSI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CVSI
Upcoming Events for CVSI
Wednesday 3rd November, 2021 Estimate
Q3 2021 CV Sciences Inc Earnings Release
Wednesday 16th March, 2022 Estimate
Q4 2021 CV Sciences Inc Earnings Release
Frequently Asked Questions for CV Sciences Inc
What is the CV Sciences Inc share price?

As of 15/10/21, shares in CV Sciences Inc are trading at $0.248, giving the company a market capitalisation of £19.7m. This share price information is delayed by 15 minutes.

How has the CV Sciences Inc share price performed this year?

Shares in CV Sciences Inc are currently trading at $0.248 and the price has moved by -51.44% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CV Sciences Inc price has moved by -61.31% over the past year.

What are the analyst and broker recommendations for CV Sciences Inc?

Of the analysts with advisory recommendations for CV Sciences Inc, there are there are currently 0 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CV Sciences Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will CV Sciences Inc next release its financial results?

CV Sciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the CV Sciences Inc dividend yield?

CV Sciences Inc does not currently pay a dividend.

Does CV Sciences Inc pay a dividend?

CV Sciences Inc does not currently pay a dividend.

When does CV Sciences Inc next pay dividends?

CV Sciences Inc does not currently pay a dividend.

How do I buy CV Sciences Inc shares?

To buy shares in CV Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CV Sciences Inc?

Shares in CV Sciences Inc are currently trading at $0.248, giving the company a market capitalisation of £19.7m.

Where are CV Sciences Inc shares listed? Where are CV Sciences Inc shares listed?

Here are the trading details for CV Sciences Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: CVSI
What kind of share is CV Sciences Inc?

Based on an overall assessment of its quality, value and momentum, CV Sciences Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CV Sciences Inc share price forecast 2021?

Shares in CV Sciences Inc are currently priced at $0.248. At that level they are trading at 77.49% discount to the analyst consensus target price of 0.00.

Analysts covering CV Sciences Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.12 for the next financial year.

How can I tell whether the CV Sciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CV Sciences Inc. Over the past six months, the relative strength of its shares against the market has been -44.7%. At the current price of $0.248, shares in CV Sciences Inc are trading at -42.63% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CV Sciences Inc PE Ratio?

We were not able to find PE ratio data for CV Sciences Inc.

Who are the key directors of CV Sciences Inc?

We were unable to find the directors for CV Sciences Inc.

Who are the major shareholders of CV Sciences Inc?

Here are the top five shareholders of CV Sciences Inc based on the size of their shareholding:

Mona (Michael Joseph Jr) Individual Investor
Percentage owned: 1.82% (1.99m shares)
Maroon (Joseph C) Individual Investor
Percentage owned: 0.68% (741k shares)
Dowling Joseph J Individual Investor
Percentage owned: 0.01% (15.0k shares)
CAPTRUST Financial Advisors Investment Advisor
Percentage owned: 0.01% (8.60k shares)
Grasser (Joerg) Individual Investor
Percentage owned: 0.01% (15.0k shares)
Similar to CVSI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.